Related Experiment Video
Updated: Dec 6, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.8K
Differentiating between Parkinson's disease patients and controls using variability in muscle activation during
Summary
Surface electromyography revealed significant differences in lower limb muscle variability for Parkinson
Area of Science:
- Neurology
- Biomedical Engineering
- Kinesiology
Background:
- Parkinson's disease (PD) is associated with motor dysfunction.
- Surface electromyography (sEMG) is explored for assessing PD-related motor control.
- Previous research on sEMG variability in PD patients has yielded inconsistent findings.
Purpose of the Study:
- To investigate muscle variability in Parkinson's disease (PD) patients.
- To compare lower limb muscle variability during gait phases between PD patients and controls.
- To determine if sEMG variability can serve as a reliable indicator of motor dysfunction in PD.
Main Methods:
- Utilized surface electromyography (sEMG) to measure muscle activity.
- Quantified muscle variability using coefficients of variance for Tibialis anterior (TA) and Medial gastrocnemius (MG) muscles.
- Employed inertial measurement units (IMUs) to accurately define gait cycle phases.
- Recruited 24 PD patients, 24 age-matched controls (CO), and 24 young controls (YC).
Main Results:
- A statistically significant difference in lower limb muscle variability was observed between PD patients and control groups across different gait phases.
- The Tibialis anterior (TA) muscle exhibited a more pronounced difference in variability compared to the Medial gastrocnemius (MG) muscle.
- These findings suggest altered muscle coordination patterns in PD patients during locomotion.
Conclusions:
- Muscle variability, particularly in the Tibialis anterior, is a potential biomarker for motor dysfunction in Parkinson's disease.
- sEMG analysis during gait provides valuable insights into the neuromuscular control deficits in PD.
- Further research can refine sEMG-based assessments for improved PD diagnosis and monitoring.
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Parkinson's Disease: Treatment
802
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
802

